DSA BreathPass™ Now Has Medical CE Certification

<Press Release, January 14th, 2022, DEEP SENSING ALGORITHMS LTD.>

World’s fastest COVID-19 detection is here

Finnish medical device company Deep Sensing Algorithms Ltd (DSA) has completed the development of the world’s first ultra-rapid COVID-19 detection technology. The DSA BreathPass™ solution, which provides a result in less than a minute, now carries the EU wide medical CE certification and is available for deliveries.

DSA BreathPass™ is a portable, handheld device that analyses exhaled breath to detect COVID-19 infection. The human defense mechanisms start immediately after the infection and the metabolic byproducts of the person’s immune response start to appear in exhaled breath within the same day.

The product is simple to use – an individual simply breathes once into the device, and an algorithm provides a result after the measuring period of 45 seconds. The device can be ready for the next individual in 2 minutes.

The solution is intended for detecting COVID-19 infection in both asymptomatic and pre-symptomatic people. Due to the early warning nature of the COVID-19 detection, it is suited for screening applications where healthy feeling and asymptomatic people wish to receive assurance of their condition.

“Our novel DSA BreathPass™ solution can make a real difference in the fight against COVID-19. It is low-cost, non-invasive, and highly scalable”, says Pekka Rissanen, CEO of DSA. “We are driven to provide a disruptive COVID screening solution that helps individuals, families, and communities return to normal at work, school, and play.”

For more information, contact Thoth Science Inc.: info@thothscience.com